Mining the Leishmania genome for novel antigens and vaccine candidates

Carla Herrera-Najera, Raúl Piña-Aguilar, Fiona Xacur-Garcia, Maria Jesus Ramirez-Sierra, Eric Dumonteil

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Leishmaniasis is a neglected disease with an estimated 12 million infected people. The recent completion of the sequencing of the Leishmania major genome has opened opportunities for the identification of targets for vaccine development. We present here the first attempt at identifying novel vaccine candidates by whole genome analysis. We predicted CD8(+) T cell epitopes from the L. major proteome and validated in vivo in mice the immunogenicity of some of the best predicted epitopes. Consensus epitope predictions from 8272 annotated protein sequences with 5-8 different algorithms allowed the identification of 78 class I CD8(+) epitopes. BALB/c mice were immunized with 26 synthetic peptides corresponding to the most likely epitopes. Fourteen (54%) resulted immunogenic, with eight being strong inducers of T cell IFNgamma production. None of the proteins from which the epitopes are derived are differentially expressed, only two may be surface proteins, eight have putative enzymatic, and metabolic activities. These epitopes and proteins represent new antigen candidates for further studies. While pathogen genomes have not yet delivered their full promise in terms of human health applications, our study opens the way for extensive genome mining for antigen identification and vaccine development against Leishmania and other pathogens.

Original languageEnglish
Pages (from-to)1293-301
Number of pages9
JournalProteomics
Volume9
Issue number5
Early online date10 Feb 2009
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Leishmania
Epitopes
Vaccines
Genes
Genome
Antigens
Leishmania major
Pathogens
Neglected Diseases
Proteins
T-Lymphocyte Epitopes
Leishmaniasis
T-cells
Proteome
Helper-Inducer T-Lymphocytes
Membrane Proteins
Health
T-Lymphocytes
Peptides

Keywords

  • Animals
  • CD8-Positive T-Lymphocytes
  • Computational Biology
  • Epitopes, T-Lymphocyte
  • Genome
  • Humans
  • Leishmania major
  • Mice
  • Mice, Inbred BALB C
  • Peptides
  • Proteome
  • Vaccination
  • Vaccines
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Herrera-Najera, C., Piña-Aguilar, R., Xacur-Garcia, F., Ramirez-Sierra, M. J., & Dumonteil, E. (2009). Mining the Leishmania genome for novel antigens and vaccine candidates. Proteomics, 9(5), 1293-301. https://doi.org/10.1002/pmic.200800533

Mining the Leishmania genome for novel antigens and vaccine candidates. / Herrera-Najera, Carla; Piña-Aguilar, Raúl; Xacur-Garcia, Fiona; Ramirez-Sierra, Maria Jesus; Dumonteil, Eric.

In: Proteomics, Vol. 9, No. 5, 03.2009, p. 1293-301.

Research output: Contribution to journalArticle

Herrera-Najera, C, Piña-Aguilar, R, Xacur-Garcia, F, Ramirez-Sierra, MJ & Dumonteil, E 2009, 'Mining the Leishmania genome for novel antigens and vaccine candidates' Proteomics, vol. 9, no. 5, pp. 1293-301. https://doi.org/10.1002/pmic.200800533
Herrera-Najera C, Piña-Aguilar R, Xacur-Garcia F, Ramirez-Sierra MJ, Dumonteil E. Mining the Leishmania genome for novel antigens and vaccine candidates. Proteomics. 2009 Mar;9(5):1293-301. https://doi.org/10.1002/pmic.200800533
Herrera-Najera, Carla ; Piña-Aguilar, Raúl ; Xacur-Garcia, Fiona ; Ramirez-Sierra, Maria Jesus ; Dumonteil, Eric. / Mining the Leishmania genome for novel antigens and vaccine candidates. In: Proteomics. 2009 ; Vol. 9, No. 5. pp. 1293-301.
@article{dac9b0255bb34b1a9482a8120e5e3840,
title = "Mining the Leishmania genome for novel antigens and vaccine candidates",
abstract = "Leishmaniasis is a neglected disease with an estimated 12 million infected people. The recent completion of the sequencing of the Leishmania major genome has opened opportunities for the identification of targets for vaccine development. We present here the first attempt at identifying novel vaccine candidates by whole genome analysis. We predicted CD8(+) T cell epitopes from the L. major proteome and validated in vivo in mice the immunogenicity of some of the best predicted epitopes. Consensus epitope predictions from 8272 annotated protein sequences with 5-8 different algorithms allowed the identification of 78 class I CD8(+) epitopes. BALB/c mice were immunized with 26 synthetic peptides corresponding to the most likely epitopes. Fourteen (54{\%}) resulted immunogenic, with eight being strong inducers of T cell IFNgamma production. None of the proteins from which the epitopes are derived are differentially expressed, only two may be surface proteins, eight have putative enzymatic, and metabolic activities. These epitopes and proteins represent new antigen candidates for further studies. While pathogen genomes have not yet delivered their full promise in terms of human health applications, our study opens the way for extensive genome mining for antigen identification and vaccine development against Leishmania and other pathogens.",
keywords = "Animals, CD8-Positive T-Lymphocytes, Computational Biology, Epitopes, T-Lymphocyte, Genome, Humans, Leishmania major, Mice, Mice, Inbred BALB C, Peptides, Proteome, Vaccination, Vaccines, Journal Article, Research Support, Non-U.S. Gov't",
author = "Carla Herrera-Najera and Ra{\'u}l Pi{\~n}a-Aguilar and Fiona Xacur-Garcia and Ramirez-Sierra, {Maria Jesus} and Eric Dumonteil",
note = "Funded by Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. Grant Number: SEP-2004-C01-47122",
year = "2009",
month = "3",
doi = "10.1002/pmic.200800533",
language = "English",
volume = "9",
pages = "1293--301",
journal = "Proteomics",
issn = "1615-9853",
publisher = "John Wiley & Sons, Ltd",
number = "5",

}

TY - JOUR

T1 - Mining the Leishmania genome for novel antigens and vaccine candidates

AU - Herrera-Najera, Carla

AU - Piña-Aguilar, Raúl

AU - Xacur-Garcia, Fiona

AU - Ramirez-Sierra, Maria Jesus

AU - Dumonteil, Eric

N1 - Funded by Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. Grant Number: SEP-2004-C01-47122

PY - 2009/3

Y1 - 2009/3

N2 - Leishmaniasis is a neglected disease with an estimated 12 million infected people. The recent completion of the sequencing of the Leishmania major genome has opened opportunities for the identification of targets for vaccine development. We present here the first attempt at identifying novel vaccine candidates by whole genome analysis. We predicted CD8(+) T cell epitopes from the L. major proteome and validated in vivo in mice the immunogenicity of some of the best predicted epitopes. Consensus epitope predictions from 8272 annotated protein sequences with 5-8 different algorithms allowed the identification of 78 class I CD8(+) epitopes. BALB/c mice were immunized with 26 synthetic peptides corresponding to the most likely epitopes. Fourteen (54%) resulted immunogenic, with eight being strong inducers of T cell IFNgamma production. None of the proteins from which the epitopes are derived are differentially expressed, only two may be surface proteins, eight have putative enzymatic, and metabolic activities. These epitopes and proteins represent new antigen candidates for further studies. While pathogen genomes have not yet delivered their full promise in terms of human health applications, our study opens the way for extensive genome mining for antigen identification and vaccine development against Leishmania and other pathogens.

AB - Leishmaniasis is a neglected disease with an estimated 12 million infected people. The recent completion of the sequencing of the Leishmania major genome has opened opportunities for the identification of targets for vaccine development. We present here the first attempt at identifying novel vaccine candidates by whole genome analysis. We predicted CD8(+) T cell epitopes from the L. major proteome and validated in vivo in mice the immunogenicity of some of the best predicted epitopes. Consensus epitope predictions from 8272 annotated protein sequences with 5-8 different algorithms allowed the identification of 78 class I CD8(+) epitopes. BALB/c mice were immunized with 26 synthetic peptides corresponding to the most likely epitopes. Fourteen (54%) resulted immunogenic, with eight being strong inducers of T cell IFNgamma production. None of the proteins from which the epitopes are derived are differentially expressed, only two may be surface proteins, eight have putative enzymatic, and metabolic activities. These epitopes and proteins represent new antigen candidates for further studies. While pathogen genomes have not yet delivered their full promise in terms of human health applications, our study opens the way for extensive genome mining for antigen identification and vaccine development against Leishmania and other pathogens.

KW - Animals

KW - CD8-Positive T-Lymphocytes

KW - Computational Biology

KW - Epitopes, T-Lymphocyte

KW - Genome

KW - Humans

KW - Leishmania major

KW - Mice

KW - Mice, Inbred BALB C

KW - Peptides

KW - Proteome

KW - Vaccination

KW - Vaccines

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1002/pmic.200800533

DO - 10.1002/pmic.200800533

M3 - Article

VL - 9

SP - 1293

EP - 1301

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 5

ER -